Reports for FRESENIUS KABI CANADA LTD

Company Name

FRESENIUS KABI CANADA LTD

Totals

Shortage reports

307

Actual shortage: 12 (4%)
Anticipated shortage: 2 (1%)
Avoided shortage: 5 (2%)
Resolved: 288 (94%)

Discontinuation Reports

0

To be discontinued: 0
Discontinued: 0
Reversed: 0

Late reports

48 (16%)

Overdue reports

3 (21%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
AMPICILLIN FOR INJECTION, USP 250MG POWDER FOR SOLUTION Actual shortage 2024-04-29 2024-04-29 226471
TOBRAMYCIN INJECTION 40MG SOLUTION Actual shortage 2022-07-07 2022-10-03 164261
DIPYRIDAMOLE INJECTION, USP 5MG LIQUID Actual shortage 2023-06-02 2024-03-28 193649
MESNA FOR INJECTION 100MG SOLUTION Actual shortage 2023-08-03 2024-01-09 201038
ADENOSINE INJECTION 3MG SOLUTION Actual shortage 2024-03-19 2024-04-01 222725
SODIUM BICARBONATE INJECTION, USP 42MG SOLUTION Actual shortage 2023-03-10 2024-04-05 186632
HYDROMORPHONE HYDROCHLORIDE INJECTION, USP 10MG SOLUTION Actual shortage 2023-08-11 2024-04-05 201627

Showing 301 to 307 of 307

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports

Showing 1 to 0 of 0